Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Hallman

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Urology|December 13, 2021
AUTHOR REPLYMegan Prunty, Laura Bukavina, J C Hallman
Urology|August 26, 2021
Anarcha, Lucy, and Betsey: The Mothers of Modern GynecologyMegan Prunty, Laura Bukavina, J C Hallman
Cancer Research|June 15, 1993
Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against human tumor xenografts: lack of cross-resistance in vivo in tumors with acquired resistance to the topoisomerase I inhibitor 9-dimethylaminomethyl-10-hydroxycamptothecinP J Houghton, P J Cheshire, J C Hallman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Evaluation of a novel bis-naphthalimide anticancer agent, DMP 840, against human xenografts derived from adult, juvenile, and pediatric cancersP J Houghton, P J Cheshire, J C Hallman, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Urology|December 13, 2021
AUTHOR REPLYMegan Prunty, Laura Bukavina, J C Hallman
Urology|August 26, 2021
Anarcha, Lucy, and Betsey: The Mothers of Modern GynecologyMegan Prunty, Laura Bukavina, J C Hallman
Cancer Research|June 15, 1993
Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against human tumor xenografts: lack of cross-resistance in vivo in tumors with acquired resistance to the topoisomerase I inhibitor 9-dimethylaminomethyl-10-hydroxycamptothecinP J Houghton, P J Cheshire, J C Hallman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Evaluation of a novel bis-naphthalimide anticancer agent, DMP 840, against human xenografts derived from adult, juvenile, and pediatric cancersP J Houghton, P J Cheshire, J C Hallman, et al.
Pageof 1